Phreesia, Inc.
PHR Healthcare Health Information Services
Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025. In the quarter to July 2026, revenue grew 10.4%, EPS grew 200.0%, free cash flow grew 43.5% and total debt rose 3,191.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PHR
Phreesia, Inc. (PHR) Piotroski F-score
Phreesia, Inc.'s Piotroski F-score for fiscal 2026 is 5 out of 9: 5 of nine tests of profitability, leverage and efficiency passed, down from 6 in fiscal 2025.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2026 | 5 | (1.00) |
| FY2025 | 6 | 2.00 |
| FY2024 | 4 | 1.00 |
| FY2023 | 3 | 0.00 |
| FY2022 | 3 | (3.00) |
| FY2021 | 6 | — |
How fiscal 2026’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 0.44% | (15.43%) | Pass | 1 |
| Positive operating cash flow | 78.81m | 32.38m | Pass | 1 |
| Rising return on assets | 0.44% | (15.43%) | Pass | 1 |
| Cash flow above net income | 76.51m | 90.91m | Pass | 1 |
| Falling long-term leverage | 0.26 | 0.02 | Fail | 0 |
| Rising current ratio | 1.53 | 1.78 | Fail | 0 |
| No new shares issued | 59,738,000 | 57,590,000 | Fail | 0 |
| Rising gross margin | 67.93% | 67.86% | Pass | 1 |
| Rising asset turnover | 0.91 | 1.11 | Fail | 0 |
| Piotroski F-score | Mixed | 5 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| WEAV Weave Communications, Inc. compare | 6 |
| NRC National Research Corporation compare | 6 |
| HSTM HealthStream, Inc. compare | 6 |
| TDOC Teladoc Health, Inc. compare | 5 |
| PHR Phreesia, Inc. | 5 |
| EVH Evolent Health, Inc compare | 5 |
| SOPH SOPHiA GENETICS SA compare | 2 |
| MDRX Veradigm Inc. compare | 1 |
| OMDA Omada Health, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover